— Know what they know.
Not Investment Advice
Also trades as: SOM.AX (ASX) · $vol 0M

SOMNF OTC

SomnoMed Limited
1W: +0.0% 1M: -46.7% 3M: -46.7% YTD: -52.9% 1Y: -45.5% 3Y: -45.5% 5Y: -86.0%
$0.24
-0.00 (-0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 36 · $52.7M mcap · 169M float · 0.0000% daily turnover · Short 77% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$52.7M
52W Range0.23895-0.51
Volume0
Avg Volume5
Beta0.80
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKaren Borg
Employees461
SectorHealthcare
IndustryMedical - Devices
IPO Date2010-10-15
20 Clarke Street
Crows Nest, NSW 2065
AU
61 2 9467 0400
About SomnoMed Limited

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms